Navigation Links
Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
Date:3/2/2009

Highly Statistically Significant Results Achieved at Two Dose Levels with No Reversal of Analgesia

SAN CARLOS, Calif., March 2 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced positive topline results today from a Phase 2 double-blind, randomized, placebo-controlled study of NKTR-118 in patients with opioid-induced constipation (OIC). NKTR-118, a peripheral opioid antagonist, is an oral once-a-day investigational drug to treat OIC, the most common and debilitating manifestation of opioid-bowel dysfunction (OBD). The Phase 2 study of NKTR-118 is terminating early on the basis of overwhelming evidence of efficacy at two different dose levels of 25 mg once daily and 50 mg once daily. The study achieved a clinically meaningful and highly statistically significant, dose-dependent increase in spontaneous bowel movements (SBMs) from baseline after the first week of NKTR-118 treatment with the 25 mg dose and the 50 mg dose versus placebo (p < 0.01 for all comparisons). Patients receiving the 25 mg dose of NKTR-118 had an average of 5.1 SBMs during the first week of treatment as compared to 1.5 SBMs per week during the baseline period. Patients receiving the 50 mg dose of NKTR-118 had an average of 5.7 SBMs during the first week of treatment versus 1.6 SBMs per week during the baseline period. The increase in SBMs versus placebo was maintained over the 28-day treatment period (p <0.01). More importantly, in the 25 mg and 50 mg dose cohorts, there was no reversal of analgesia as measured by a change in pain Numerical Rating Scale (NRS) and no increase in opiate use.

"These data show that NKTR-118 taken orally once-daily at the 25 mg and 50 mg dose levels dramatically increased bowel movements within the first week of treatment for patients with OIC," said Lynn R. Webster, M.D., Medical Director, Lifetre
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
2. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
3. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
4. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
5. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
6. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
7. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
8. TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
9. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
10. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
11. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... 29, 2014  On Oct. 2, some 24,000 Lilly ... company,s seventh Global Day of Service. Building on Lilly,s ... together in a single, coordinated effort to improve the ... "I,m so proud of this tradition, and of ... to strengthening the communities around the world where we ...
(Date:9/29/2014)... SANTA ANA, Calif. , Sept. 29, 2014 /PRNewswire/ ... premier supplier of certified child-resistant packaging, accessories and consulting ... that company co-founder Nick Kovacevich has assumed ... Kovacevich, who co-founded the company in 2010 and worked ... company after a brief hiatus focusing on other ventures. ...
(Date:9/29/2014)... N.J. , Sept. 29, 2014  ADM ... that it has entered into an affiliation with ... in Cambridge, Massachusetts founded ... appointed member of ADMT,s Advisory Board. ... medical technology companies with specialized services and finances ...
Breaking Medicine Technology:Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 2Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 3Kush Bottles Co-Founder Steps into Role of CEO 2ADM Tronics Joins Triotech Ventures Technology Consortium 2ADM Tronics Joins Triotech Ventures Technology Consortium 3
(Date:9/30/2014)... SOLON, OH (PRWEB) September 30, 2014 ... wiper blades sporting the iconic pink ribbon in support ... October, a popular month for businesses and non-profits to ... this worthwhile cause. , AutoTex PINK is a woman-owned ... windshield wipers. They are committed to partnering with ...
(Date:9/30/2014)... 30, 2014 Loffler Companies, an ... technology and services was recognized by BEI as ... (FCE) in 2013. This prestigious rating means that ... time and for an extended period following, optimizing ... 20 years BEI Services has been the trusted ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Julie ... Hudson Allergy , will discuss how restaurants can ... and other special dietary restrictions at the 2014 ... Food Service Professionals, October 21 in New York City. ... incredibly important topic to such an engaged industry audience. ...
(Date:9/30/2014)... Up to 45% of the population snores ... have sleep apnea. Of these, only 10% have been ... tolerate their prescribed medical device known as CPAP (continuous ... which supports the airway during sleep. , In today’s ... and increasingly difficult to get. Snoring and sleep apnea ...
(Date:9/30/2014)... vitamin D3 compared with placebo did not reduce hospital ... stay, hospital mortality, or the risk of death at ... were critically ill, according to a study published in ... online to coincide with its presentation at the European ... A high prevalence of low vitamin D levels has ...
Breaking Medicine News(10 mins):Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 2Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 3Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 2Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 3Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 3Health News:Snoring: Robs People and Their Bed Partners of the Rest They Need to Face Daily Challenges 2Health News:Snoring: Robs People and Their Bed Partners of the Rest They Need to Face Daily Challenges 3Health News:High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes 2
... and an affordable follow-up test to identify children with ... first chemotherapy regimen, // has been developed by researchers ... have a good response may then be treated by ... ,This new test is based on testing ...
... center in Houston stated yesterday that ultrasound is fast becoming ... pregnant woman. // ,Dr. Wei Yang of ... to educate young women that the symptomatic breast cancer that ... pregnant, and so they should not wait to seek medical ...
... on a study to gauge if exercise can prevent ... after chemotherapy.// The study is being funded by a ... Armstrong. ,Charles Matthews, Ph.D., and Laurel Brown, ... lead a team of researchers at Vanderbilt-Ingram as they ...
... from the University of Alabama, Birmingham, told a jury at ... no significant difference in the rate of heart attacks //among ... drug Vioxx is produced and marketed by Merck & Co.'s. ... that the studies, covering a total of about 28,000 patients, ...
... that snake venom can be used for easing the debilitating ... development manager at the Shulov Institute of Sciences (SIS) in ... an analgesic based on snake venom could be on sale ... Palestinian viper - the most common snake in Israel - ...
... of an ambitious public-private initiative for the establishment of ... health professionals. // This announcement seeks to address the ... sections of the society. ,The new venture ... aims to impart multi-disciplinary knowledge through a network of ...
Cached Medicine News:Health News:Inexpensive ALL Follow-Up Test Developed By St. Jude Researchers 2Health News:Inexpensive ALL Follow-Up Test Developed By St. Jude Researchers 3Health News:Could Long Tern Vioxx Users Suffer From Heart Attacks? 2
... brightly illuminated hand-held potential vision tester measures ... and glaucoma. Potential vision testing requires ... Meter or RAM (formerly known as the ... Clip (clip with a pinhole disc and ...
... are the latest innovation ... portable battery-powered EEG headboxes. ... new mechanical design, and ... standard MOBEE24plus and MOBEE32 ...
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: